4//SEC Filing
Klein Matthew B. 4
Accession 0001808968-25-000003
CIK 0001070081other
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 5:20 PM ET
Size
7.3 KB
Accession
0001808968-25-000003
Insider Transaction Report
Form 4
Klein Matthew B.
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Award
Common Stock
2025-12-01+15,625→ 353,392 total - Sale
Common Stock
2025-12-02$79.07/sh−3,428$271,052→ 349,964 total
Footnotes (2)
- [F1]Represents the number of shares of the Issuer's common stock underlying restricted stock units ("RSUs") earned upon the vesting of performance-based restricted stock units ("PSUs") granted in December 2024. On December 1, 2025, the Issuer's board of directors certified the Issuer's achievement of a pre-established milestone set forth in the PSUs, which resulted in the reported RSUs being earned. Each earned RSU represents the contingent right to receive one share of the Issuer's common stock upon vesting. The earned RSUs immediately vested as to 7,812 shares on December 1, 2025 in connection with being earned and are scheduled to vest with respect to the remaining 7,813 shares on December 1, 2026.
- [F2]Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the RSU grant to satisfy tax withholding obligations in connection with the vesting of the earned RSUs with respect to 7,812 shares on December 1, 2025.
Documents
Issuer
PTC THERAPEUTICS, INC.
CIK 0001070081
Entity typeother
Related Parties
1- filerCIK 0001808968
Filing Metadata
- Form type
- 4
- Filed
- Dec 2, 7:00 PM ET
- Accepted
- Dec 3, 5:20 PM ET
- Size
- 7.3 KB